Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Current Leases (2019 - 2025)

Plus Therapeutics (PSTV) has disclosed Current Leases for 7 consecutive years, with $56000.0 as the latest value for Q4 2025.

  • Quarterly Current Leases rose 27.27% to $56000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $56000.0 through Dec 2025, up 27.27% year-over-year, with the annual reading at $56000.0 for FY2025, 27.27% up from the prior year.
  • Current Leases for Q4 2025 was $56000.0 at Plus Therapeutics, up from $21000.0 in the prior quarter.
  • The five-year high for Current Leases was $127000.0 in Q2 2021, with the low at $21000.0 in Q3 2025.
  • Average Current Leases over 5 years is $89315.8, with a median of $107000.0 recorded in 2022.
  • Peak annual rise in Current Leases hit 27.27% in 2025, while the deepest fall reached 69.12% in 2025.
  • Over 5 years, Current Leases stood at $106000.0 in 2021, then rose by 3.77% to $110000.0 in 2022, then rose by 9.09% to $120000.0 in 2023, then tumbled by 63.33% to $44000.0 in 2024, then grew by 27.27% to $56000.0 in 2025.
  • According to Business Quant data, Current Leases over the past three periods came in at $56000.0, $21000.0, and $30000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.